PTC Therapeutics PTCT Gain Loss On Extinguishment Of Debt Sale Of Future Royalties And Debt Issuance Costs

Gain Loss On Extinguishment Of Debt Sale Of Future Royalties And Debt Issuance Costs at other companies

Avis Budget GroupCAR

-$1.5M+71.4%

CopartCPRT

$0-100%

Delta Air LinesDAL

-$4M—

Warner Music GroupWMG

-$7M—

Royal Caribbean GroupRCL

-$60M-500%

Starwood Property TrustSTWD

-$335K—

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept ptct:GainLossOnExtinguishmentOfDebtSaleOfFutureRoyaltiesAndDebtIssuanceCosts.

The official record: PTC Therapeutics’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's gain loss on extinguishment of debt sale of future royalties and debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's gain loss on extinguishment of debt sale of future royalties and debt issuance costs?: PTC Therapeutics (PTCT) reported gain loss on extinguishment of debt sale of future royalties and debt issuance costs of -$13.91M in Q4 2023.
What does gain loss on extinguishment of debt sale of future royalties and debt issuance costs mean?: Captures the realized financial impact from the early retirement or modification of debt obligations, including those structured as sales of future royalty streams. It indicates the cost or benefit associated with restructuring capital obligations to optimize the balance sheet.